aluates Reports

$ 0.0

Automative

Global Alpha-Fetoprotein (AFP) Biomarker Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-25Z16693

BUY CHAPTERS

Global Alpha-Fetoprotein (AFP) Biomarker Market Research Report 2024

Code: QYRE-Auto-25Z16693

Report

March 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

HCC

Fujifilm

Eli Lilly and Company

Fujirebio

Roche Diagnostics

Fapon Biotech

LabCorp

Thermo Fisher Scientific

Abcam

Bio-Techne

MyBioSource

RayBiotech

Cusabio

Elabscience Biotechnology

Abbexa

Alpha-Fetoprotein (AFP) Biomarker Market

Hepatocellular carcinoma (HCC) is the seventh most common cancer diagnosis worldwide with high associated mortality. HCC is a unique malignancy, as it typically arises in the setting of chronic liver disease in particular cirrhosis, with competing risks of liver failure, contributing to its low 5-year survival rates of 18%–20%. More than half of worldwide HCC-related deaths occur in Asia, due to endemic hepatitis B (HBV) infection. HCC incidence is rising in many Western countries due to the rising prevalence of nonalcoholic fatty liver disease, alcohol-related liver disease, and hepatitis C (HCV)-related complications despite the availability of direct acting antiviral therapies. The search for biomarkers in hepatocellular carcinoma continues despite recent approvals for immune checkpoint inhibitor combinations, tyrosine kinase inhibitors [TKIs], and antiangiogenesic agents. Biomarkers can be either predictive or prognostic and the only biomarker that has been used clinically is the prognostic biomarker α-fetoprotein (AFP).

The global Alpha-Fetoprotein (AFP) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Alpha-Fetoprotein (AFP) Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Alpha-Fetoprotein (AFP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam and Bio-Techne, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Alpha-Fetoprotein (AFP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-Fetoprotein (AFP) Biomarker.

Report Scope

The Alpha-Fetoprotein (AFP) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alpha-Fetoprotein (AFP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alpha-Fetoprotein (AFP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Alpha-Fetoprotein (AFP) Biomarker Market Report

Report Metric	Details
Report Name	Alpha-Fetoprotein (AFP) Biomarker Market
Segment by Type	Liver Cancer Testes Cancer Ovarian Cancer Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam, Bio-Techne, MyBiosource, RayBiotech, CUSABIO, Elabscience Biotechnology, Abbexa
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha-Fetoprotein (AFP) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alpha-Fetoprotein (AFP) Biomarker Market report?

Ans: The main players in the Alpha-Fetoprotein (AFP) Biomarker Market are FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam, Bio-Techne, MyBiosource, RayBiotech, CUSABIO, Elabscience Biotechnology, Abbexa

What are the Application segmentation covered in the Alpha-Fetoprotein (AFP) Biomarker Market report?

Ans: The Applications covered in the Alpha-Fetoprotein (AFP) Biomarker Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Alpha-Fetoprotein (AFP) Biomarker Market report?

Ans: The Types covered in the Alpha-Fetoprotein (AFP) Biomarker Market report are Liver Cancer, Testes Cancer, Ovarian Cancer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Liver Cancer

1.2.3 Testes Cancer

1.2.4 Ovarian Cancer

1.2.5 Others

1.3 Market by Application

1.3.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Perspective (2019-2030)

2.2 Alpha-Fetoprotein (AFP) Biomarker Growth Trends by Region

2.2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Region (2019-2024)

2.2.3 Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Region (2025-2030)

2.3 Alpha-Fetoprotein (AFP) Biomarker Market Dynamics

2.3.1 Alpha-Fetoprotein (AFP) Biomarker Industry Trends

2.3.2 Alpha-Fetoprotein (AFP) Biomarker Market Drivers

2.3.3 Alpha-Fetoprotein (AFP) Biomarker Market Challenges

2.3.4 Alpha-Fetoprotein (AFP) Biomarker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Revenue

3.1.1 Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Revenue (2019-2024)

3.1.2 Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Players (2019-2024)

3.2 Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Alpha-Fetoprotein (AFP) Biomarker Revenue

3.4 Global Alpha-Fetoprotein (AFP) Biomarker Market Concentration Ratio

3.4.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alpha-Fetoprotein (AFP) Biomarker Revenue in 2023

3.5 Alpha-Fetoprotein (AFP) Biomarker Key Players Head office and Area Served

3.6 Key Players Alpha-Fetoprotein (AFP) Biomarker Product Solution and Service

3.7 Date of Enter into Alpha-Fetoprotein (AFP) Biomarker Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Alpha-Fetoprotein (AFP) Biomarker Breakdown Data by Type

4.1 Global Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Type (2019-2024)

4.2 Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Type (2025-2030)

5 Alpha-Fetoprotein (AFP) Biomarker Breakdown Data by Application

5.1 Global Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Application (2019-2024)

5.2 Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)

6.2 North America Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)

6.4 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)

7.2 Europe Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)

7.4 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)

8.2 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2019-2024)

8.4 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)

9.2 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)

9.4 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)

10.2 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)

10.4 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 FUJIFILM

11.1.1 FUJIFILM Company Detail

11.1.2 FUJIFILM Business Overview

11.1.3 FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Introduction

11.1.4 FUJIFILM Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.1.5 FUJIFILM Recent Development

11.2 Eli Lilly and Company

11.2.1 Eli Lilly and Company Company Detail

11.2.2 Eli Lilly and Company Business Overview

11.2.3 Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Introduction

11.2.4 Eli Lilly and Company Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.2.5 Eli Lilly and Company Recent Development

11.3 Fujirebio

11.3.1 Fujirebio Company Detail

11.3.2 Fujirebio Business Overview

11.3.3 Fujirebio Alpha-Fetoprotein (AFP) Biomarker Introduction

11.3.4 Fujirebio Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.3.5 Fujirebio Recent Development

11.4 Roche Diagnostics

11.4.1 Roche Diagnostics Company Detail

11.4.2 Roche Diagnostics Business Overview

11.4.3 Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Introduction

11.4.4 Roche Diagnostics Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.4.5 Roche Diagnostics Recent Development

11.5 Fapon Biotech

11.5.1 Fapon Biotech Company Detail

11.5.2 Fapon Biotech Business Overview

11.5.3 Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Introduction

11.5.4 Fapon Biotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.5.5 Fapon Biotech Recent Development

11.6 Labcorp

11.6.1 Labcorp Company Detail

11.6.2 Labcorp Business Overview

11.6.3 Labcorp Alpha-Fetoprotein (AFP) Biomarker Introduction

11.6.4 Labcorp Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.6.5 Labcorp Recent Development

11.7 Thermo Fisher Scientific

11.7.1 Thermo Fisher Scientific Company Detail

11.7.2 Thermo Fisher Scientific Business Overview

11.7.3 Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Introduction

11.7.4 Thermo Fisher Scientific Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.7.5 Thermo Fisher Scientific Recent Development

11.8 Abcam

11.8.1 Abcam Company Detail

11.8.2 Abcam Business Overview

11.8.3 Abcam Alpha-Fetoprotein (AFP) Biomarker Introduction

11.8.4 Abcam Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.8.5 Abcam Recent Development

11.9 Bio-Techne

11.9.1 Bio-Techne Company Detail

11.9.2 Bio-Techne Business Overview

11.9.3 Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Introduction

11.9.4 Bio-Techne Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.9.5 Bio-Techne Recent Development

11.10 MyBiosource

11.10.1 MyBiosource Company Detail

11.10.2 MyBiosource Business Overview

11.10.3 MyBiosource Alpha-Fetoprotein (AFP) Biomarker Introduction

11.10.4 MyBiosource Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.10.5 MyBiosource Recent Development

11.11 RayBiotech

11.11.1 RayBiotech Company Detail

11.11.2 RayBiotech Business Overview

11.11.3 RayBiotech Alpha-Fetoprotein (AFP) Biomarker Introduction

11.11.4 RayBiotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.11.5 RayBiotech Recent Development

11.12 CUSABIO

11.12.1 CUSABIO Company Detail

11.12.2 CUSABIO Business Overview

11.12.3 CUSABIO Alpha-Fetoprotein (AFP) Biomarker Introduction

11.12.4 CUSABIO Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.12.5 CUSABIO Recent Development

11.13 Elabscience Biotechnology

11.13.1 Elabscience Biotechnology Company Detail

11.13.2 Elabscience Biotechnology Business Overview

11.13.3 Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Introduction

11.13.4 Elabscience Biotechnology Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.13.5 Elabscience Biotechnology Recent Development

11.14 Abbexa

11.14.1 Abbexa Company Detail

11.14.2 Abbexa Business Overview

11.14.3 Abbexa Alpha-Fetoprotein (AFP) Biomarker Introduction

11.14.4 Abbexa Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

11.14.5 Abbexa Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

HCC

Fujifilm

Eli Lilly and Company

Fujirebio

Roche Diagnostics

Fapon Biotech

LabCorp

Thermo Fisher Scientific

Abcam

Bio-Techne

MyBioSource

RayBiotech

Cusabio

Elabscience Biotechnology

Abbexa

List of Tables

Table 1. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Liver Cancer

Table 3. Key Players of Testes Cancer

Table 4. Key Players of Ovarian Cancer

Table 5. Key Players of Others

Table 6. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2019-2024)

Table 10. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2025-2030)

Table 12. Alpha-Fetoprotein (AFP) Biomarker Market Trends

Table 13. Alpha-Fetoprotein (AFP) Biomarker Market Drivers

Table 14. Alpha-Fetoprotein (AFP) Biomarker Market Challenges

Table 15. Alpha-Fetoprotein (AFP) Biomarker Market Restraints

Table 16. Global Alpha-Fetoprotein (AFP) Biomarker Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Players (2019-2024)

Table 18. Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-Fetoprotein (AFP) Biomarker as of 2023)

Table 19. Ranking of Global Top Alpha-Fetoprotein (AFP) Biomarker Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Alpha-Fetoprotein (AFP) Biomarker Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Alpha-Fetoprotein (AFP) Biomarker Product Solution and Service

Table 23. Date of Enter into Alpha-Fetoprotein (AFP) Biomarker Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Type (2019-2024)

Table 27. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Type (2025-2030)

Table 29. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Application (2019-2024)

Table 31. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Application (2025-2030)

Table 33. North America Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 48. FUJIFILM Company Detail

Table 49. FUJIFILM Business Overview

Table 50. FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Product

Table 51. FUJIFILM Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 52. FUJIFILM Recent Development

Table 53. Eli Lilly and Company Company Detail

Table 54. Eli Lilly and Company Business Overview

Table 55. Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Product

Table 56. Eli Lilly and Company Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 57. Eli Lilly and Company Recent Development

Table 58. Fujirebio Company Detail

Table 59. Fujirebio Business Overview

Table 60. Fujirebio Alpha-Fetoprotein (AFP) Biomarker Product

Table 61. Fujirebio Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 62. Fujirebio Recent Development

Table 63. Roche Diagnostics Company Detail

Table 64. Roche Diagnostics Business Overview

Table 65. Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Product

Table 66. Roche Diagnostics Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 67. Roche Diagnostics Recent Development

Table 68. Fapon Biotech Company Detail

Table 69. Fapon Biotech Business Overview

Table 70. Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Product

Table 71. Fapon Biotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 72. Fapon Biotech Recent Development

Table 73. Labcorp Company Detail

Table 74. Labcorp Business Overview

Table 75. Labcorp Alpha-Fetoprotein (AFP) Biomarker Product

Table 76. Labcorp Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 77. Labcorp Recent Development

Table 78. Thermo Fisher Scientific Company Detail

Table 79. Thermo Fisher Scientific Business Overview

Table 80. Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Product

Table 81. Thermo Fisher Scientific Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 82. Thermo Fisher Scientific Recent Development

Table 83. Abcam Company Detail

Table 84. Abcam Business Overview

Table 85. Abcam Alpha-Fetoprotein (AFP) Biomarker Product

Table 86. Abcam Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 87. Abcam Recent Development

Table 88. Bio-Techne Company Detail

Table 89. Bio-Techne Business Overview

Table 90. Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Product

Table 91. Bio-Techne Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 92. Bio-Techne Recent Development

Table 93. MyBiosource Company Detail

Table 94. MyBiosource Business Overview

Table 95. MyBiosource Alpha-Fetoprotein (AFP) Biomarker Product

Table 96. MyBiosource Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 97. MyBiosource Recent Development

Table 98. RayBiotech Company Detail

Table 99. RayBiotech Business Overview

Table 100. RayBiotech Alpha-Fetoprotein (AFP) Biomarker Product

Table 101. RayBiotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 102. RayBiotech Recent Development

Table 103. CUSABIO Company Detail

Table 104. CUSABIO Business Overview

Table 105. CUSABIO Alpha-Fetoprotein (AFP) Biomarker Product

Table 106. CUSABIO Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 107. CUSABIO Recent Development

Table 108. Elabscience Biotechnology Company Detail

Table 109. Elabscience Biotechnology Business Overview

Table 110. Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Product

Table 111. Elabscience Biotechnology Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 112. Elabscience Biotechnology Recent Development

Table 113. Abbexa Company Detail

Table 114. Abbexa Business Overview

Table 115. Abbexa Alpha-Fetoprotein (AFP) Biomarker Product

Table 116. Abbexa Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)

Table 117. Abbexa Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Type: 2023 VS 2030

Figure 3. Liver Cancer Features

Figure 4. Testes Cancer Features

Figure 5. Ovarian Cancer Features

Figure 6. Others Features

Figure 7. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Alpha-Fetoprotein (AFP) Biomarker Report Years Considered

Figure 13. Global Alpha-Fetoprotein (AFP) Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Alpha-Fetoprotein (AFP) Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region: 2023 VS 2030

Figure 16. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Players in 2023

Figure 17. Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-Fetoprotein (AFP) Biomarker as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Alpha-Fetoprotein (AFP) Biomarker Revenue in 2023

Figure 19. North America Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)

Figure 21. United States Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)

Figure 25. Germany Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2019-2030)

Figure 33. China Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)

Figure 41. Mexico Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)

Figure 45. Turkey Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. FUJIFILM Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 48. Eli Lilly and Company Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 49. Fujirebio Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 50. Roche Diagnostics Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 51. Fapon Biotech Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 52. Labcorp Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 54. Abcam Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 55. Bio-Techne Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 56. MyBiosource Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 57. RayBiotech Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 58. CUSABIO Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 59. Elabscience Biotechnology Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 60. Abbexa Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HCC Hepatocellular Carcinoma Biomarker Market Research Report 2024

Alpha fetoprotein Tumor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alpha Fetoprotein Quantitative Assay Kit Market Research Report 2024

Global Alpha Fetoprotein AFP ELISA Kit Market Research Report 2025

Global Alpha Fetoprotein Isoform Detection Market Research Report 2025

Global Alpha Fetoprotein AFP Tumor Marker Test Reagents Market Research Report 2024

Global Alpha Fetoprotein Testing Reagents Market Research Report 2024

Global Hepatocellular Carcinoma Targeted Drug Market Research Report 2025

Global Hepatoma Cell Targeted Drug Market Research Report 2025

Global Liver Cancer Therapeutics Market Insights Forecast to 2030

Global Liver Cancer Molecular Diagnostics Market Research Report 2024

Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Biomarker Market Research Report 2024

Global Hepatocellular Carcinoma Monoclonal Antibody Market Research Report 2025

Global Alpha fetoprotein ELISA Kit Market Research Report 2024

Tumor Markers for Primary Liver Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Myeloid Leukemia Biomarker Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Alcoholic Steatohepatitis Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions